A carregar...
Sodium-glucose co-transporter-2 inhibitors: A cardiovascular outcome trial analysis
Cardiovascular outcome trials (CVOTs) have to be done by sponsors who wish to launch new antidiabetic drugs in the US, since the December 2008 US Food and Drug Administration ruling, which was subsequently accepted by the European Medicines (Evaluation) Agency (EMA) in 2012. However, the medical com...
Na minha lista:
| Publicado no: | Perspect Clin Res |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer - Medknow
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8011522/ https://ncbi.nlm.nih.gov/pubmed/33816202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/picr.PICR_156_19 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|